Factors associated with progression to critical illness in 28 days among COVID-19 patients: results from a tertiary care hospital in Istanbul, Turkey
View ORCID ProfileUluhan Sili, View ORCID ProfilePinar Ay, View ORCID ProfileAhmet Topuzoglu, View ORCID ProfileHuseyin Bilgin, View ORCID ProfileElif Tukenmez Tigen, View ORCID ProfileBuket Erturk Sengel, View ORCID ProfileDilek Yagci Caglayik, View ORCID ProfileBaran Balcan, View ORCID ProfileDerya Kocakaya, View ORCID ProfileSehnaz Olgun Yildizeli, View ORCID ProfileFethi Gul, View ORCID ProfileBeliz Bilgili, View ORCID ProfileRabia Can Sarinoglu, View ORCID ProfileAysegul Karahasan Yagci, View ORCID ProfileLutfiye Mulazimoglu Durmusoglu, View ORCID ProfileEmel Eryuksel, View ORCID ProfileZekaver Odabasi, View ORCID ProfileHaner Direskeneli, View ORCID ProfileSait Karakurt, View ORCID ProfileIsmail Cinel, View ORCID ProfileVolkan Korten
doi: https://doi.org/10.1101/2020.10.09.20209775
Uluhan Sili
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Pinar Ay
2Department of Public Health, Marmara University School of Medicine, Istanbul, Turkey
Ahmet Topuzoglu
2Department of Public Health, Marmara University School of Medicine, Istanbul, Turkey
Huseyin Bilgin
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Elif Tukenmez Tigen
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Buket Erturk Sengel
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Dilek Yagci Caglayik
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Baran Balcan
3Department of Pulmonary Medicine, Marmara University School of Medicine, Istanbul, Turkey
Derya Kocakaya
3Department of Pulmonary Medicine, Marmara University School of Medicine, Istanbul, Turkey
Sehnaz Olgun Yildizeli
3Department of Pulmonary Medicine, Marmara University School of Medicine, Istanbul, Turkey
Fethi Gul
4Department of Anesthesiology and Intensive Care, Marmara University School of Medicine, Istanbul, Turkey
Beliz Bilgili
4Department of Anesthesiology and Intensive Care, Marmara University School of Medicine, Istanbul, Turkey
Rabia Can Sarinoglu
5Department of Medical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Aysegul Karahasan Yagci
5Department of Medical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Lutfiye Mulazimoglu Durmusoglu
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Emel Eryuksel
3Department of Pulmonary Medicine, Marmara University School of Medicine, Istanbul, Turkey
Zekaver Odabasi
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Haner Direskeneli
6Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey
Sait Karakurt
3Department of Pulmonary Medicine, Marmara University School of Medicine, Istanbul, Turkey
Ismail Cinel
4Department of Anesthesiology and Intensive Care, Marmara University School of Medicine, Istanbul, Turkey
Volkan Korten
1Department of Infectious Diseases and Clinical Microbiology, Marmara University School of Medicine, Istanbul, Turkey
Article usage
Posted October 11, 2020.
Factors associated with progression to critical illness in 28 days among COVID-19 patients: results from a tertiary care hospital in Istanbul, Turkey
Uluhan Sili, Pinar Ay, Ahmet Topuzoglu, Huseyin Bilgin, Elif Tukenmez Tigen, Buket Erturk Sengel, Dilek Yagci Caglayik, Baran Balcan, Derya Kocakaya, Sehnaz Olgun Yildizeli, Fethi Gul, Beliz Bilgili, Rabia Can Sarinoglu, Aysegul Karahasan Yagci, Lutfiye Mulazimoglu Durmusoglu, Emel Eryuksel, Zekaver Odabasi, Haner Direskeneli, Sait Karakurt, Ismail Cinel, Volkan Korten
medRxiv 2020.10.09.20209775; doi: https://doi.org/10.1101/2020.10.09.20209775
Factors associated with progression to critical illness in 28 days among COVID-19 patients: results from a tertiary care hospital in Istanbul, Turkey
Uluhan Sili, Pinar Ay, Ahmet Topuzoglu, Huseyin Bilgin, Elif Tukenmez Tigen, Buket Erturk Sengel, Dilek Yagci Caglayik, Baran Balcan, Derya Kocakaya, Sehnaz Olgun Yildizeli, Fethi Gul, Beliz Bilgili, Rabia Can Sarinoglu, Aysegul Karahasan Yagci, Lutfiye Mulazimoglu Durmusoglu, Emel Eryuksel, Zekaver Odabasi, Haner Direskeneli, Sait Karakurt, Ismail Cinel, Volkan Korten
medRxiv 2020.10.09.20209775; doi: https://doi.org/10.1101/2020.10.09.20209775
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)